Illumina

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Illumina and other ETFs, options, and stocks.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Francis A. deSouza
CEOFrancis A. deSouza
Employees
9,800
Employees9,800
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
9,800
Employees9,800

ILMN Key Statistics

Market cap
29.65B
Market cap29.65B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.06M
Average volume2.06M
High today
$194.53
High today$194.53
Low today
$179.75
Low today$179.75
Open price
$193.60
Open price$193.60
Volume
2.82M
Volume2.82M
52 Week high
$428.00
52 Week high$428.00
52 Week low
$173.45
52 Week low$173.45

ILMN News

Barron's 20h
Jobs Report, Constellation Brands Stock, Illumina, and More to Watch This Week

Text size It’s the quiet before the storm of third-quarter earnings season, which ramps up during the second week of October. The main event on the economic ca...

Jobs Report, Constellation Brands Stock, Illumina, and More to Watch This Week
Barron's 3d
Bill Gates Says Genomics Shouldn’t Help Just Rich People

Text size Bill Gates speaks onstage at the TIME100 Summit in 2022. Jemal Countess/Getty Images for TIME A thousand medical researchers and doctors gathered in...

Bill Gates Says Genomics Shouldn’t Help Just Rich People
Axios 4d
DNA sequencing behemoth Illumina unveils new line of instruments - Axios

Competition is intensifying in the DNA sequencing industry, which has long been dominated by sequencing behemoth Illumina. Driving the news: Illumina, which ha...

DNA sequencing behemoth Illumina unveils new line of instruments - Axios

Analyst ratings

50%

of 18 ratings
Buy
33.3%
Hold
50%
Sell
16.7%

ILMN Earnings

$0.00
$0.63
$1.26
$1.89
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours

More ILMN News

Bloomberg 4d
Illumina Aims to Push Genetics Beyond the Lab With $200 Genome

(Bloomberg) -- Illumina Inc. says it can read a person’s entire genetic code for as little as $200 with its new sequencing machine, bringing the company within...

Illumina Aims to Push Genetics Beyond the Lab With $200 Genome
Barron's 4d
Illumina’s New Gene-Sequencing Products Pressure Challengers

Text size Surrounded by challengers promising faster, cheaper gene-sequencing systems, industry leader Illumina announced its own faster, cheaper gene-readers...

Illumina’s New Gene-Sequencing Products Pressure Challengers
Reuters 4d
Illumina launches next-generation DNA sequencers - Reuters.com

The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo SAN DIEGO,...

Illumina launches next-generation DNA sequencers - Reuters.com
Wired 4d
The Era of Fast, Cheap Genome Sequencing Is Here - WIRED

The human genome is made of more than 6 billion letters, and each person has a unique configuration of As, Cs, Gs, and Ts—the molecular building blocks that mak...

The Era of Fast, Cheap Genome Sequencing Is Here - WIRED
CNBC 5d
Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more

Check out the companies making headlines in midday trading. Apple — Apple shares fell 3.4% on Wednesday following a report that the company is ditching plans t...

Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more
Barron's 5d
Illumina’s New Gene Sequencers Are Almost Here. What They Need to Deliver.

Text size Illumina ’s gene sequencers powered many of the recent breakthroughs in biology and medicine, but the San Diego-based firm hasn’t introduced a new pr...

Illumina’s New Gene Sequencers Are Almost Here. What They Need to Deliver.
Axios 5d
Back to business: health care M&A activity expected to accelerate - Axios

The Justice Department's failed attempt to block UnitedHealth's $13 billion acquisition of health tech Change Healthcare could bode well for other mega-deals as...

Back to business: health care M&A activity expected to accelerate - Axios
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.